Emron Managed Care News 5-29-15

Too Many Women Who Need Bone Screening Aren’t Getting It http://bit.ly/1Hu5YM2 Too few womens at high risk for osteoporosis are being tested for the bone-depleting condition, while too many women at low-risk are being screened, a new study suggests.   Boehringer Ingelheim’s combination COPD therapy Stiolto Respimat garners FDA approval http://bit.ly/1Hu8e61 Boehringer Ingelheim announced Tuesday that the FDA approved … Continued